This blue chip stock is at the intersection of cutting-edge technology and healthcare. Shares of Intuitive Surgical (ISRG 0.06%) have gained momentum following strong first-quarter results. The stock is up nearly 30% this year. The company continues to benefit from the global trend toward minimally invasive surgeries powering demand for its da Vinci robotic surgical systems. A positive growth outlook supported by overall solid fundamentals offers a good setup when evaluating any investment opportunity. That ...

Intuitive Surgical, Inc. (ISRG) ended the recent trading session at $442.56, demonstrating a +0.06% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.16%. Elsewhere, the Dow saw an upswing of 0.04%, while the tech-heavy Nasdaq appreciated by 0.49%. Prior to today's trading, shares of the company had gained 10.29% over the past month. This has outpaced the Medical sector's gain of 2.32% and the S&P 500's gain of 3.22% in that time. Investors will be eagerly watching ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Intuitive Surgical, Inc. (ISRG) . Intuitive Surgical currently has an average brokerage recomm ...

FX Empire Logo English check-icon Italiano Español Português Deutsch ﺔﯿﺑﺮﻌﻟا Français Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial ...

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $422.90, moving -1.21% from the previous trading session. This move lagged the S&P 500's daily gain of 0.23%. On the other hand, the Dow registered a loss of 0.17%, and the technology-centric Nasdaq increased by 0.34%. Coming into today, shares of the company had gained 7.19% in the past month. In that same time, the Medical sector gained 2.69%, while the S&P 500 gained 3.96%. Investors will be eagerly watching for the performance of Intu ...

Robotic-assisted surgery is a massive growth opportunity, and Intuitive Surgical looks to be in prime position to benefit from the potential. Nvidia (NASDAQ: NVDA) is the talk of the stock market these days. The artificial intelligence (AI) stock has hit a $3 trillion valuation and it looks unstoppable. But the danger in jumping aboard that bandwagon is that sooner or later, the excitement stops, and you may find out you bought shares near or at the peak. Investors have fallen into trouble with exciting gro ...

Loading... Loading... Intuitive Surgical, Inc. ISRG is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on the Artificial Intelligence front, is expected to contribute further. However, procedure adoption risks and stiff competition persist. Shares of this Zacks Rank #3 (Hold) company have risen 23.8% year to date compared with the industry's 6.6% growth. The S&P 500 Index has gained 12.4% during ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Intuitive Surgical, Inc. (ISRG) . Intuitive Surgical currently has an average brokerage recomm ...

文章核心观点 - 该报告提供了Intuitive Surgical公司的产品管线分析,包括公司概况、主要产品和服务、在研产品以及正在进行的临床试验等信息 [1][2][3] - 报告的目的是帮助读者了解公司的发展动态,为决策制定和竞争策略提供支持 [4] 公司概况 - Intuitive Surgical是一家专注于研发和生产外科手术机器人系统的公司,主要产品包括da Vinci手术系统等 [5][6][7] - 公司在全球范围内拥有多个子公司和研发中心,是业内的主要参与者之一 [39][40] 在研产品概览 - 公司目前有多款在研产品,涵盖手术机器人系统、手术器械、成像设备等,处于不同研发阶段 [8][10] - 主要在研产品包括:da Vinci SP手术系统、da Vinci手术用钉仓、单孔内窥镜手术系统、FLIm光学设备、Iris Gen 2.0等 [11][14][16][18][20] - 公司还在开发下一代da Vinci 5多孔手术机器人和多孔手术系统等新产品 [24][26] 临床试验进展 - 公司部分在研产品正在进行临床试验,如da Vinci SP手术系统和SureForm手术钉仓 [13][34] - 临床试验涉及的适应症包括泌尿外科手术、胸腔手术等 [13][34] 竞争格局 - 公司主要竞争对手包括Medrobotics、Ethicon Endo-Surgery、Olympus等医疗器械企业 [35][36] - 公司不断推出新产品和技术,保持在行业内的领先地位 [41][42]

文章核心观点 - 直观外科(ISRG)近期获得FDA批准,修改了其da Vinci X和Xi机器人手术系统在前列腺切除术中的标签说明 [1][2] - 这一修改是基于2007-2014年间的真实世界数据,显示机器人辅助前列腺切除术的5-10年总体生存率与非机器人手术相似 [2] - 这一标签修改有助于进一步评估其他癌症手术的长期生存结果,推进监管科学领域的发展 [5] 公司概况 - 公司的da Vinci手术系统旨在为外科医生提供增强视野、机器人和计算机支持以及高清3D视觉,以帮助他们进行微创手术 [9] - 公司目前拥有7款获批的da Vinci手术系统,包括标准、S、Si、Xi、X、SP和最新的第五代da Vinci 5系统 [10][11] - 公司除了在美国市场,还在欧洲、中国、日本和韩国等地区商业化销售da Vinci系统,未来还计划进一步拓展国际市场 [12][13] 行业前景 - 根据MarketsandMarkets的报告,全球手术机器人市场规模预计将从2022年的85亿美元增长到2027年的184亿美元,年复合增长率为16.6% [14] - 微创手术带来的诸多优势,如更好的筛查、更高的精确度、更短的住院时间以及更少的疼痛和痛苦,推动了该技术的需求和接受度,从而推动了市场的扩张 [15]